We are constantly researching winning stocks with insider activity. Insider activity (officers and directors of the firm) is informative as they are able to outperform the market on average. This is explained by their superior insider information and/or superior value investing capabilities.
Today, we discuss Bristol Myers Squibb (BMY), a large cap biopharmaceutical company primarily focused on oncology. Its director Dinesh C. Paliwal purchased $500K worth of shares on June 15th. The company looks attractively valued compared to peers and has a lot of growth potential from its merger with Celgene, finished on